Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer.
第一作者:
Yi,Xiao
第一单位:
Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);基因, erbB-2(Genes, erbB-2);人类(Humans);肿瘤辅助疗法(Neoadjuvant Therapy);回顾性研究(Retrospective Studies)
DOI
10.3389/fimmu.2022.877825
PMID
35663978
发布时间
2022-07-16
- 浏览0
Frontiers in immunology
877825页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文